NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/18/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,988.61 mln
Float227 mln
Earnings Date08/12/2026
EPS
0.68
Decent
P / E
12.22
Fair value
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.32
Borderline
1-Year Forecast
17.60
Transformational upside
Relative Strength
84
/ 100
Strongly outperforming
Business Description
ADMA Biologics is a U.S.-based company that produces and sells medicines made from human plasma, primarily used to help patients with weakened immune systems or serious infections like Hepatitis B. Founded in 2004 and based in Ramsey, New Jersey, the company runs its own plasma collection centers and manufacturing operations to support its product line. Its treatments reach patients through wholesalers, specialty pharmacies, and distributors across the United States and in other countries.
